Selected research
Industry Research
Antidiuretic Hormone (ADH) Industry Research Report 2026
Market perspective
The global Antidiuretic Hormone (ADH) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Antidiuretic Hormone (ADH) market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Antidiuretic Hormone (ADH) market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Antidiuretic Hormone (ADH) market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Antidiuretic Hormone (ADH) include Shanghai Soho-Yiming Pharmaceuticals, Novartis, Pfizer, Ferring Pharmaceuticals, Fresenius Kabi, Par Pharmaceutical and Astellas Pharma, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Antidiuretic Hormone (ADH) market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Antidiuretic Hormone (ADH).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antidiuretic Hormone (ADH) Market by Company
Shanghai Soho-Yiming Pharmaceuticals
Novartis
Pfizer
Ferring Pharmaceuticals
Fresenius Kabi
Par Pharmaceutical
Astellas Pharma
Antidiuretic Hormone (ADH) Segment by Type
Subcutaneous Injection
Intravenous Injection
Intramuscular Injection
Antidiuretic Hormone (ADH) Segment by Application
Vasodilatory Shock
Gastrointestinal Bleeding
Ventricular Tachycardia & Fibrillation
Anti-Diuretic Hormone Deficiency
Antidiuretic Hormone (ADH) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiuretic Hormone (ADH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antidiuretic Hormone (ADH) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiuretic Hormone (ADH).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Antidiuretic Hormone (ADH) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Subcutaneous Injection
- Intravenous Injection
- Intramuscular Injection
Applications
- Vasodilatory Shock
- Gastrointestinal Bleeding
- Ventricular Tachycardia & Fibrillation
- Anti-Diuretic Hormone Deficiency
Companies covered
- Shanghai Soho-Yiming Pharmaceuticals
- Novartis
- Pfizer
- Ferring Pharmaceuticals
- Fresenius Kabi
- Par Pharmaceutical
- Astellas Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Antidiuretic Hormone (ADH) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Subcutaneous Injection
- 2.2.3 Intravenous Injection
- 2.2.4 Intramuscular Injection
- 2.3 Antidiuretic Hormone (ADH) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Vasodilatory Shock
- 2.3.3 Gastrointestinal Bleeding
- 2.3.4 Ventricular Tachycardia & Fibrillation
- 2.3.5 Anti-Diuretic Hormone Deficiency
- 2.4 Assumptions and Limitations
3 Antidiuretic Hormone (ADH) Breakdown Data by Type
- 3.1 Global Antidiuretic Hormone (ADH) Historic Market Size by Type (2021-2026)
- 3.2 Global Antidiuretic Hormone (ADH) Forecasted Market Size by Type (2027-2032)
4 Antidiuretic Hormone (ADH) Breakdown Data by Application
- 4.1 Global Antidiuretic Hormone (ADH) Historic Market Size by Application (2021-2026)
- 4.2 Global Antidiuretic Hormone (ADH) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Antidiuretic Hormone (ADH) Market Perspective (2021-2032)
- 5.2 Global Antidiuretic Hormone (ADH) Growth Trends by Region
- 5.2.1 Global Antidiuretic Hormone (ADH) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Antidiuretic Hormone (ADH) Historic Market Size by Region (2021-2026)
- 5.2.3 Antidiuretic Hormone (ADH) Forecasted Market Size by Region (2027-2032)
- 5.3 Antidiuretic Hormone (ADH) Market Dynamics
- 5.3.1 Antidiuretic Hormone (ADH) Industry Trends
- 5.3.2 Antidiuretic Hormone (ADH) Market Drivers
- 5.3.3 Antidiuretic Hormone (ADH) Market Challenges
- 5.3.4 Antidiuretic Hormone (ADH) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Antidiuretic Hormone (ADH) Players by Revenue
- 6.1.1 Global Top Antidiuretic Hormone (ADH) Players by Revenue (2021-2026)
- 6.1.2 Global Antidiuretic Hormone (ADH) Revenue Market Share by Players (2021-2026)
- 6.2 Global Antidiuretic Hormone (ADH) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Antidiuretic Hormone (ADH) Head Office and Area Served
- 6.4 Global Antidiuretic Hormone (ADH) Players, Product Type & Application
- 6.5 Global Antidiuretic Hormone (ADH) Manufacturers Established Date
- 6.6 Global Antidiuretic Hormone (ADH) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Antidiuretic Hormone (ADH) Market Size (2021-2032)
- 7.2 North America Antidiuretic Hormone (ADH) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 7.4 North America Antidiuretic Hormone (ADH) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Antidiuretic Hormone (ADH) Market Size (2021-2032)
- 8.2 Europe Antidiuretic Hormone (ADH) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 8.4 Europe Antidiuretic Hormone (ADH) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Antidiuretic Hormone (ADH) Market Size (2021-2032)
- 9.2 Asia-Pacific Antidiuretic Hormone (ADH) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Antidiuretic Hormone (ADH) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Antidiuretic Hormone (ADH) Market Size (2021-2032)
- 10.2 South America Antidiuretic Hormone (ADH) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 10.4 South America Antidiuretic Hormone (ADH) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Antidiuretic Hormone (ADH) Market Size (2021-2032)
- 11.2 Middle East & Africa Antidiuretic Hormone (ADH) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Antidiuretic Hormone (ADH) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Antidiuretic Hormone (ADH) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Shanghai Soho-Yiming Pharmaceuticals
- 12.1.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
- 12.1.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
- 12.1.3 Shanghai Soho-Yiming Pharmaceuticals Revenue in Antidiuretic Hormone (ADH) Business (2021-2026)
- 12.1.4 Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio
- 12.1.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
- 12.2 Novartis
- 12.2.1 Novartis Company Information
- 12.2.2 Novartis Business Overview
- 12.2.3 Novartis Revenue in Antidiuretic Hormone (ADH) Business (2021-2026)
- 12.2.4 Novartis Antidiuretic Hormone (ADH) Product Portfolio
- 12.2.5 Novartis Recent Developments
- 12.3 Pfizer
- 12.3.1 Pfizer Company Information
- 12.3.2 Pfizer Business Overview
- 12.3.3 Pfizer Revenue in Antidiuretic Hormone (ADH) Business (2021-2026)
- 12.3.4 Pfizer Antidiuretic Hormone (ADH) Product Portfolio
- 12.3.5 Pfizer Recent Developments
- 12.4 Ferring Pharmaceuticals
- 12.4.1 Ferring Pharmaceuticals Company Information
- 12.4.2 Ferring Pharmaceuticals Business Overview
- 12.4.3 Ferring Pharmaceuticals Revenue in Antidiuretic Hormone (ADH) Business (2021-2026)
- 12.4.4 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Product Portfolio
- 12.4.5 Ferring Pharmaceuticals Recent Developments
- 12.5 Fresenius Kabi
- 12.5.1 Fresenius Kabi Company Information
- 12.5.2 Fresenius Kabi Business Overview
- 12.5.3 Fresenius Kabi Revenue in Antidiuretic Hormone (ADH) Business (2021-2026)
- 12.5.4 Fresenius Kabi Antidiuretic Hormone (ADH) Product Portfolio
- 12.5.5 Fresenius Kabi Recent Developments
- 12.6 Par Pharmaceutical
- 12.6.1 Par Pharmaceutical Company Information
- 12.6.2 Par Pharmaceutical Business Overview
- 12.6.3 Par Pharmaceutical Revenue in Antidiuretic Hormone (ADH) Business (2021-2026)
- 12.6.4 Par Pharmaceutical Antidiuretic Hormone (ADH) Product Portfolio
- 12.6.5 Par Pharmaceutical Recent Developments
- 12.7 Astellas Pharma
- 12.7.1 Astellas Pharma Company Information
- 12.7.2 Astellas Pharma Business Overview
- 12.7.3 Astellas Pharma Revenue in Antidiuretic Hormone (ADH) Business (2021-2026)
- 12.7.4 Astellas Pharma Antidiuretic Hormone (ADH) Product Portfolio
- 12.7.5 Astellas Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst